Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2000
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing post-operative care, orthopedic treatment, and rehabilitation. As of December 31, 2000, it operated 139 clinics in 30 states. The business model relies on physician referrals and revenue from commercial insurance, workers' compensation, Medicare, and personal injury cases. The Company utilizes a partnership structure where managing therapists often hold equity interests in their respective clinics.
Key Financial Metrics
| Metric (in thousands) | 2000 | 1999 |
|---|---|---|
| Net Revenues | $63,222 | $51,368 |
| Net Income | $3,735 | $2,394 |
| Earnings Per Share (Diluted) | $0.52 | $0.34 |
| Operating Cash Flow | $8,861 | $5,050 |
| Cash and Cash Equivalents | $2,071 | $4,030 |
| Long-Term Debt | $7,226 | $8,087 |
| Working Capital | $10,420 | $12,493 |
| Current Ratio | 4.14 | 6.79 |
Note: Per share data reflects a two-for-one stock split effected in January 2001.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 23% to $63.2 million, driven by a 23% increase in patient visits (to 697,000) and the opening of 28 new clinics. New clinics contributed 27% of the revenue increase.
- Profitability: Net income rose 56% to $3.7 million. Operating margins improved as clinic operating costs decreased as a percentage of revenue from 74% in 1999 to 72% in 2000.
- Capital Structure: The Company repurchased 1.13 million shares of common stock in August 2000 for $6.3 million, funded by cash and a new line of credit. This reduced cash reserves and increased the debt-to-equity ratio from 0.76 to 0.85.
- Debt Conversions: $850,000 of Convertible Subordinated Notes were converted to common stock during 2000. In January 2001, the Company exercised its right to force the conversion of the remaining Initial Series and Series B notes.
- Discontinued Operations: The Company discontinued its surgery center initiative in March 2000, incurring $369,000 in costs for the year.
Guidance, Outlook, and Risks
- Outlook: Management plans to open between 30 and 35 new clinics in 2001. The Company expects new clinics to initially operate at lower margins due to start-up costs but anticipates favorable long-term impact.
- Regulatory Risks: The Company is heavily dependent on Medicare reimbursement. While a moratorium on the $1,500 annual therapy cap was extended through 2002, future healthcare reform and regulatory interpretations (Fraud and Abuse Law, Stark Law) pose significant risks.
- Competition: The industry is highly competitive, with competition from hospital outpatient departments and private clinics. The Company competes on quality, cost, and location accessibility.
- Liquidity: Management believes existing funds and operating cash flows are sufficient to meet needs through 2002. The Company maintains a $500,000 revolving line of credit.
Investor Verification Checklist
- Debt Conversion Impact: Verify the dilution effect of the mandatory conversion of remaining Convertible Subordinated Notes (Series A and B) completed in January 2001.
- Stock Repurchase Rationale: Assess the impact of the $6.3 million stock buyback on liquidity and future expansion capital.
- Medicare Reimbursement: Monitor the status of the moratorium on the $1,500 Medicare therapy cap and potential legislative changes post-2002.
- New Clinic Performance: Track the ramp-up time and profitability of the 28 clinics opened in 2000 to validate the 2001 growth projections.
- Related Party Transactions: Review the $415,000 in interest expense paid on notes held by directors and the terms of the convertible debt held by related parties.